Transient receptor potential canonical type 3 channels and blood pressure in humans

Journal of Hypertension

Volumn 27, Issue 6, 2009, Pages 1217-1223

  Thilo, Florian ^a   Baumunk, Daniel ^a   Krause, Hans ^a   Schrader, Mark ^a   Miller, Kurt ^a   Loddenkemper, Christoph ^a   Zakrzewicz, Andreas ^a   Krueger, Katharina ^a   Zidek, Walter ^a   Tepel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood pressure; Human endothelium; Transient receptor potential canonical channel

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; 2 MORPHOLINO 8 PHENYLCHROMONE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WORTMANNIN;

ARTICLE; BLOOD PRESSURE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 67649644420     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832a5a9f     Document Type: Article

References (23)

1. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, Ito Y. Transient receptor potential channels in cardiovascular function and disease. Circ Res 2006; 99:119-131.
2. Liu D, Scholze A, Zhu Z, Kreutz R, Wehland-von-Trebra M, Zidek W, Tepel M. Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens 2005; 18:1503-1507.
3. Dietrich A, Mederos Y, Schnitzler M, Gollasch M, Gross V, Storch U, et al. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol 2005; 25:6980-6989.
4. Liu DY, Thilo F, Scholze A, Wittstock A, Zhao ZG, Harteneck C, et al. Increased store-operated and 1 -oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension. J Hypertens 2007; 25:799-808.
5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9:669-676.
6. Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, Peale F, et al. Neuropilin-1 binds to VEGF1 21 and regulates endothelial cell migration and sprouting. J Biol Chem 2007; 282:24049-24056.
7. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 2006; 47:629-633.
8. Watanabe T, Kanome T, Miyazaki A, Katagiri T. Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 2006; 29:375-387.
9. Thijssen DH, Rongen GA, Smits P, Hopman MT. Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations. J Physiol 2008; 586:31 9-324.
10. Jankowski V, Tölle M, Vanholder R, Schönfelder G, van der Giet M, Henning L, et al. Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 2005; 11:223-227.
11. Chlench S, Mecha Disassa N, Hohberg M, Hoffmann C, Pohlkamp T, Beyer G, et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett 2007; 581:673-680.
12. Meri S, Mattila P, Renkonen R. Regulation of CD59 expression on the human endothelial cell line FAhy926. Eur J Immunol 1993; 23:2511-2516.
13. Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, et al. Expression of von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000; 85:281-288.
14. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999; 397:259-263.
15. Lee YM, Kim BJ, Kim HJ, Yang DK, Zhu MH, Lee KP, et al. TRPC5 as a candidate for the nonselective cation channel activated by muscarinic stimulation in murine stomach. Am J Physiol Gastrointest Liver Physiol 2003; 284:G604-G616.
16. Schaefer M, Plant TD, Obukhov AG, Hofmann T, Gudermann T, Schultz G. Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5. J Biol Chem 2000; 275:1 751 7-21 726.
17. 2+ entry channels. J Biol Chem 2001; 276:1 8888-1 8896.
18. Prakriya M, Lewis RS. Potentiation and inhibition of Ca(2+) release-activated Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. J Physiol 2001; 536:3-19.
19. Kaelin WG Jr. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 2007; 13:680s-684s.
20. Brugarolas J. Renal-cell carcinoma: molecular pathways and therapies. N Engl J Med 2007; 356:185-187.
21. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 1999; 178:235-246.
22. Kwon Y, Hofmann T, Montell C. Integration of phosphoinositide- and calmodulin-mediated regulation of TRPC6. Mol Cell 2007; 25:491-503.
23. McLaughlin JK, Lipworth L, Tarone RE. Epidemiologic aspects of renal cell carcinoma. Semin Oncol 2006; 33:527-533.